Serum Metabolomics Profiling to Identify Biomarkers for Unstable Angina
Table 1
Demographic and clinical characteristics of unstable angina patients and healthy controls.
Controls
UAP group
P
Male
72 (54.55%)
53 (52.48%)
0.099
0.753
Age (years)
1.265
0.209
Hypertension
71 (53.79%)
60 (59.40%)
0.734
0.392
Diabetes
28 (21.21%)
30 (29.70%)
2.206
0.137
Smoking
40 (30.30%)
48 (47.52%)
7.220
0.007
SBP (mmHg)
0.792
0.430
DBP (mmHg)
1.927
0.057
HR (BPM)
0.391
0.697
BMI (Kg/m2)
0.202
0.117
WC (cm)
1.119
0.266
LV (mm)
0.610
0.543
EF (%)
1.430
0.156
TC (mmol/L)
0.451
0.653
TG (mmol/L)
1.29 (0.84, 1.59)
1.51 (1.00, 1.84)
2.235
0.025
HDL-C (mmol/L)
1.27 (0.97, 1.52)
1.06 (0.84, 1.27)
2.857
0.004
LDL-C (mmol/L)
2.026
0.038
GLU (mmol/L)
5.63 (5.00, 6.00)
6.37 (5.10, 6.60)
1.087
0.277
CR (umol/L)
65.65 (56.00, 73.00)
68.98 (58.00, 76.00)
1.047
0.295
UA (mmol/L)
0.513
0.609
Data are presented as mean ± SD. SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; BMI: body mass index; WC: waist circumference; LV: left ventricular end diastolic diameter; EF: left ventricular ejection fraction; TC: total cholesterol; TG: triglycerides; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; GLU: blood glucose; CR: creatinine; UA: uric acid. indicates statistically different between groups.
